Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy
Benefits of early administration of ivabradine in stabilized patients hospitalized due to worsening heart failure: insights from the Optimize Heart Failure Care Program
Effects of empagliflozin on exercise capacity and LV diastolic function in HFpEF and type-2 diabetes mellitus: rationale and design of prospective intervention study
Acute Effect of Sacubitril/Valsartan on Depression Score in patients with Acute Decompansed Heart Failure on the First Day of Theraphy:A Prospective Analysis from Our Center Experiences
Speaker:
Associate Professor T. Kivrak (Elazig, TR)
Titration process and predictors of achieving target dose of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction attending to an outpatient heart failure clinic.